Concepedia

Katsuya Maeda

KM

Statistics

Publications

18

Citations

891

H-Index

15

Active since

1996

Affiliations

Japan Tobacco (Japan)(Current)

Kyoto University

Japan Tobacco (United States)

Array BioPharma (United States)

Orphagen Pharmaceuticals (United States)

Katsuya Maeda is an author at Japan Tobacco (Japan) specializing in drug discovery, medicinal chemistry, and chemistry.

Publications per year

1996–2021

18

Publications

18

Radical Multicomponent Carboamination of [1.1.1]Propellane

Junichiro Kanazawa, Katsuya Maeda, Masanobu Uchiyama · Journal of the American Chemical Society · 2017 · 219 citations

, , +9

Discovery of a Highly Potent and Selective MEK Inhibitor: GSK1120212 (JTP-74057 DMSO Solvate)

Hiroyuki Abé, Shinichi Kikuchi, Kazuhide Hayakawa et al. · ACS Medicinal Chemistry Letters · 2011 · 193 citations

, , +13

SAR Exploration Guided by LE and Fsp <sup>3</sup> : Discovery of a Selective and Orally Efficacious RORγ Inhibitor

Kazuyuki Hirata, Masayuki Kotoku, Noriyoshi Seki et al. · ACS Medicinal Chemistry Letters · 2015 · 59 citations · Full text

, , +16

Discovery of a Janus Kinase Inhibitor Bearing a Highly Three-Dimensional Spiro Scaffold: JTE-052 (Delgocitinib) as a New Dermatological Agent to Treat Inflammatory Skin Disorders

Satoru Noji, Yoshinori Hara, Tomoya Miura et al. · Journal of Medicinal Chemistry · 2020 · 56 citations · Full text

, , +17

Discovery of (1<i>S</i>,2<i>R</i>,3<i>R</i>)-2,3-Dimethyl-2-phenyl-1-sulfamidocyclopropanecarboxylates: Novel and Highly Selective Aggrecanase Inhibitors

Makoto Shiozaki, Katsuya Maeda, Tomoya Miura et al. · Journal of Medicinal Chemistry · 2011 · 51 citations · Full text

, , +11

1–5 of 18